These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

368 related items for PubMed ID: 30187450

  • 1. Dornase alfa for cystic fibrosis.
    Yang C, Montgomery M.
    Cochrane Database Syst Rev; 2018 Sep 06; 9(9):CD001127. PubMed ID: 30187450
    [Abstract] [Full Text] [Related]

  • 2. Dornase alfa for cystic fibrosis.
    Yang C, Montgomery M.
    Cochrane Database Syst Rev; 2021 Mar 18; 3(3):CD001127. PubMed ID: 33735508
    [Abstract] [Full Text] [Related]

  • 3. Dornase alfa for cystic fibrosis.
    Yang C, Chilvers M, Montgomery M, Nolan SJ.
    Cochrane Database Syst Rev; 2016 Apr 04; 4():CD001127. PubMed ID: 27043279
    [Abstract] [Full Text] [Related]

  • 4. Dornase alfa for cystic fibrosis.
    Jones AP, Wallis C.
    Cochrane Database Syst Rev; 2010 Mar 17; (3):CD001127. PubMed ID: 20238314
    [Abstract] [Full Text] [Related]

  • 5. Inhaled mannitol for cystic fibrosis.
    Nevitt SJ, Thornton J, Murray CS, Dwyer T.
    Cochrane Database Syst Rev; 2020 May 01; 5(5):CD008649. PubMed ID: 32358807
    [Abstract] [Full Text] [Related]

  • 6. Inhaled mannitol for cystic fibrosis.
    Nevitt SJ, Thornton J, Murray CS, Dwyer T.
    Cochrane Database Syst Rev; 2018 Feb 09; 2(2):CD008649. PubMed ID: 29424930
    [Abstract] [Full Text] [Related]

  • 7. Inhaled mannitol for cystic fibrosis.
    Nolan SJ, Thornton J, Murray CS, Dwyer T.
    Cochrane Database Syst Rev; 2015 Oct 09; (10):CD008649. PubMed ID: 26451533
    [Abstract] [Full Text] [Related]

  • 8. Nebulised hypertonic saline for cystic fibrosis.
    Wark P, McDonald VM.
    Cochrane Database Syst Rev; 2018 Sep 27; 9(9):CD001506. PubMed ID: 30260472
    [Abstract] [Full Text] [Related]

  • 9. Nebulised hypertonic saline for cystic fibrosis.
    Wark P, McDonald VM, Smith S.
    Cochrane Database Syst Rev; 2023 Jun 14; 6(6):CD001506. PubMed ID: 37319354
    [Abstract] [Full Text] [Related]

  • 10. Recombinant human deoxyribonuclease for cystic fibrosis.
    Jones AP, Wallis CE.
    Cochrane Database Syst Rev; 2003 Jun 14; (3):CD001127. PubMed ID: 12917899
    [Abstract] [Full Text] [Related]

  • 11. Timing of dornase alfa inhalation for cystic fibrosis.
    Dentice R, Elkins M.
    Cochrane Database Syst Rev; 2021 Mar 09; 3(3):CD007923. PubMed ID: 33686652
    [Abstract] [Full Text] [Related]

  • 12. Timing of dornase alfa inhalation for cystic fibrosis.
    Dentice R, Elkins M.
    Cochrane Database Syst Rev; 2018 Nov 12; 11(11):CD007923. PubMed ID: 30480755
    [Abstract] [Full Text] [Related]

  • 13. Deoxyribonuclease for cystic fibrosis.
    Kearney CE, Wallis CE.
    Cochrane Database Syst Rev; 2000 Nov 12; (2):CD001127. PubMed ID: 10796748
    [Abstract] [Full Text] [Related]

  • 14. Timing of dornase alfa inhalation for cystic fibrosis.
    Dentice R, Elkins M.
    Cochrane Database Syst Rev; 2016 Jul 26; 7(7):CD007923. PubMed ID: 27457496
    [Abstract] [Full Text] [Related]

  • 15. Inhaled anti-pseudomonal antibiotics for long-term therapy in cystic fibrosis.
    Smith S, Rowbotham NJ.
    Cochrane Database Syst Rev; 2022 Nov 14; 11(11):CD001021. PubMed ID: 36373968
    [Abstract] [Full Text] [Related]

  • 16. Recombinant growth hormone therapy for cystic fibrosis in children and young adults.
    Thaker V, Carter B, Putman M.
    Cochrane Database Syst Rev; 2018 Dec 17; 12(12):CD008901. PubMed ID: 30557452
    [Abstract] [Full Text] [Related]

  • 17. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K, Williams J, Qi YP, Gutman J, Yeung L, Mai C, Finkelstain J, Mehta S, Pons-Duran C, Menéndez C, Moraleda C, Rogers L, Daniels K, Green P.
    Cochrane Database Syst Rev; 2022 Feb 01; 2(2022):. PubMed ID: 36321557
    [Abstract] [Full Text] [Related]

  • 18. Timing of hypertonic saline inhalation for cystic fibrosis.
    Elkins M, Dentice R.
    Cochrane Database Syst Rev; 2020 Feb 28; 2(2):CD008816. PubMed ID: 32107770
    [Abstract] [Full Text] [Related]

  • 19. Omega-3 fatty acid supplementation for cystic fibrosis.
    Watson H, Stackhouse C.
    Cochrane Database Syst Rev; 2020 Apr 10; 4(4):CD002201. PubMed ID: 32275788
    [Abstract] [Full Text] [Related]

  • 20. Potentiators (specific therapies for class III and IV mutations) for cystic fibrosis.
    Skilton M, Krishan A, Patel S, Sinha IP, Southern KW.
    Cochrane Database Syst Rev; 2019 Jan 07; 1(1):CD009841. PubMed ID: 30616300
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.